Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development Post author: Post published:June 17, 2024 Post category:uncategorized Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays. You Might Also Like FIND Lp(a) machine learning model aims to transform cardiovascular disease screening September 19, 2024 A unifying marker streamlines macrophage research across age and sex June 27, 2024 New tool revolutionizes primer design for infectious disease detection March 4, 2025
FIND Lp(a) machine learning model aims to transform cardiovascular disease screening September 19, 2024